Bioorganic and Medicinal Chemistry p. 3619 - 3633 (2018)
Update date:2022-08-28
Topics:
Zhang, Hao
Wang, Jin
Zhao, Hong-Yi
Yang, Xue-Yan
Lei, Hao
Xin, Minhang
Cao, Yong-Xiao
Zhang, San-Qi
In the present study, a new class of compounds containing pyrido[3,4-d]pyrimidine scaffold with an acrylamide moiety was designed as irreversible EGFR-TKIs to overcome acquired EGFR-T790M resistance. The most promising compound 25h inhibited HCC827 and H1975 cells growth with the IC50 values of 0.025 μM and 0.49 μM, respectively. Meanwhile, 25h displayed potent inhibitory activity against the EGFRL858R (IC50 = 1.7 nM) and EGFRL858R/T790M (IC50 = 23.3 nM). 25h could suppress EGFR phosphorylation in HCC827 and H1975 cell lines and significantly induce the apoptosis of HCC827 cells. Additionally, compound 25h could remarkably inhibit cancer growth in established HCC827 xenograft mouse model at 50 mg/kg in vivo. These results indicated that the 2,4-disubstituted 6-(5-substituted pyridin-2-amino)pyrido[3,4-d]pyrimidine derivatives can serve as effective EGFR inhibitors and potent anticancer agents.
View MoreDaqing New Century Fine Chemical Co., Ltd.
Contact:010-57126694
Address:No.39, jinxing cun, honggang district
Jiangxi Huashi Pharmaceutical Co., Ltd
Contact:+86-795-4509628
Address:Ningbo Ave., Fengtian Industrial Park, Fengxin Country, Jiangxi, China.
jintan yufan Medicine Raw materials Co.,Ltd.
Contact:86-519-82808282
Address:6th,Jincheng Huangzhuang
website:http://www.jairadhesales.com
Contact:0091-79-26431096
Address:309 Harikrupa Tower,Nr old Sharda Mandir Char Rasta,Ellisbridge
Shanghai Run-Biotech Co., Ltd.
website:http://www.run-biotech.com
Contact:+86-21-31576854/57171705 / 57171706
Address:second floor, building 3, No.999, jiangyue Road, minghang District, Shanghai, China
Doi:10.1021/acs.joc.6b00478
(2016)Doi:10.1007/s11243-012-9634-z
(2012)Doi:10.1107/S0108270197004162
(1997)Doi:10.1080/15257779908041562
(1999)Doi:10.1006/jcat.2002.3640
(2002)Doi:10.1002/adsc.201000621
(2011)